129
Participants
Start Date
June 2, 2017
Primary Completion Date
February 16, 2021
Study Completion Date
March 14, 2022
Nivolumab
Specified Dose on Specified Days
Local Institution - 0013, Parktown, Johannesburg
Local Institution - 0011, Port Elizabeth
Local Institution - 0012, George
Broome Oncology, Johnson City
Guthrie Medical Group Sayre, Sayre
Alabama Oncology, Birmingham
St Vincent Frontier Cancer Center, Billings
Los Angeles Hematology Oncology Medical Group, Los Angeles
Local Institution - 0003, Craiova
Local Institution - 0016, Tokyo
Local Institution - 0018, Koto-ku
Local Institution - 0017, Nagoya
Local Institution - 0023, Osaka
Local Institution - 0015, Kingston
Local Institution - 0014, Oshawa
Local Institution - 0001, Toronto
Local Institution - 0006, Sector 2
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY